VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $409,037 | -36.3% | 39,597 | 0.0% | 0.10% | -32.4% |
| Q2 2023 | $641,867 | +13.4% | 39,597 | +16.5% | 0.15% | +10.4% |
| Q1 2023 | $565,934 | +85.1% | 33,990 | +4.5% | 0.13% | +81.1% |
| Q4 2022 | $305,726 | +133.4% | 32,524 | 0.0% | 0.07% | +94.7% |
| Q3 2022 | $131,000 | +22.4% | 32,524 | 0.0% | 0.04% | +46.2% |
| Q2 2022 | $107,000 | +55.1% | 32,524 | +41.0% | 0.03% | +85.7% |
| Q1 2022 | $69,000 | -19.8% | 23,074 | +23.5% | 0.01% | -17.6% |
| Q4 2021 | $86,000 | -26.5% | 18,679 | 0.0% | 0.02% | -37.0% |
| Q3 2021 | $117,000 | +4.5% | 18,679 | 0.0% | 0.03% | +8.0% |
| Q2 2021 | $112,000 | +10.9% | 18,679 | +4.5% | 0.02% | -3.8% |
| Q1 2021 | $101,000 | +18.8% | 17,879 | +21.8% | 0.03% | +13.0% |
| Q4 2020 | $85,000 | +2.4% | 14,679 | -1.3% | 0.02% | +4.5% |
| Q3 2020 | $83,000 | – | 14,879 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |